Citius Oncology Inc.CTORNASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q4 2025 | -5.37% |
| Q3 2025 | 14.69% |
| Q2 2025 | -70.11% |
| Q1 2025 | 148.27% |
| Q4 2024 | -2.44% |
| Q3 2024 | 14.55% |
| Q2 2024 | -16.13% |
| Q1 2024 | 17.46% |
| Q4 2023 | -0.29% |
| Q3 2023 | -6.74% |
| Q2 2023 | 34.35% |
| Q1 2023 | -1.60% |
| Q4 2022 | -82.18% |
| Q3 2022 | 225.15% |
| Q2 2022 | 0.00% |